Delivery Order SPE2DB20D2104-SPE2DB24FQ83W
Award Date 10/20/23
Potential Completion Date 10/23/23
Potential Value $1.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $1,192.77 for the pharmaceutical product LINZESS 72 MCG CAPSULE UU 30S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 21, 2023. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,205.64 for the provision of LINZESS 145 MCG CAPSULE. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), and has an ultimate completion date of February 2, 2022. The contract is a Firm Fixed Price arrangement without any set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,707.34 firm-fixed-price delivery order is for the pharmaceutical product LINZESS 145 MCG CAPSULE. The contract has an ultimate completion date of October 21, 2021. This appears to be part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award from the Defense Logistics Agency (DLA) was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,411.52 firm-fixed-price delivery order is for the supply of LINZESS 290 MCG capsules. The contract has an ultimate completion date of February 1, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award is a delivery order with a ceiling value of $3,447.03, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of LINZESS 145 MCG CAPSULE pharmaceutical product and has a completion date of May 19, 2023. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Linzess 290 MCG capsules. The $7,821.77 contract is a firm fixed-price delivery order with a completion date of March 9, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $1,615.02 with a Firm Fixed Price pricing type and an ultimate completion date of October 16, 2023. The contract is for the pharmaceutical product LINZESS 145 MCG CAPSULE UU 30S. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of LINZESS 290 MCG CAPSULE in the amount of $3,680.45. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,311.19 firm fixed-price delivery order is for LINZESS 145 MCG capsules and has an ultimate completion date of April 13, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- The U.S. Defense Logistics Agency (DLA) has awarded a $13,368.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp, a division of the parent company Cencora, Inc. The contract is for the delivery of LINZESS 145 MCG capsules and does not have a set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025, which enables the DLA to efficiently procure a...